The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe. The report emphasizes the demands and ongoing trends of the global Cell-Free DNA (cfDNA) Testing market, more importantly, across the major regions of the market. Additionally, our analysts have included SWOT analysis and Porter’s Five Forces analysis in the report to offer a better understanding of the competitive spectrum of this ever-evolving industry.
The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. The latest report offers a profound analysis of the present market scenario, its key product types, end-user landscape, application outlook, leading regions, competitive terrain, and the leading companies’ detailed profiles. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period. However, The expensive equipment and lack of skilled healthcare professionals are expected to restrain the market growth in the forecast timeframe.
Key Highlights From The Report
- In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilent’s product portfolio and its presence in North America.
- Cell-free fetal DNA is a non-invasive procedure and therefore does not pose a health risk of CVS (chorionic villus sampling) or amniocentesis, like pain and any slight chance of infection. Due to these benefits, the cell-free fetal DNA segment held the largest market share of 48.8% in the Cell-Free DNA (cfDNA) testing market, in 2019.
To get a sample copy of the Global Cell-Free DNA (cfDNA) Testing Market report, visit @ https://www.emergenresearch.com/request-sample/156
The study performs a historical assessment of the Cell-Free DNA (cfDNA) Testing from 2017 to 2018, focusing on the market trends, revenue share, growth rate, production capacity, pricing structure, and other vital aspects during that period. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.
The global Cell-Free DNA (cfDNA) Testing market consists of various segments, including product type outlook, application spectrum, end-user overview, leading regions, and the competitive analysis. The report further provides information regarding the value chain, emerging market sectors, and the technological advancements in the industry to benefit readers and businesses looking to invest in this industry.
Key Market Competitors Profiled in the Report:
- Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.
The global Cell-Free DNA (cfDNA) Testing market report evaluates the latest economic scenario in terms of value and volume. It highlights the key growth drivers, restraints, production capacity, demand & supply ratio, import/export status, growth rate, and other critical aspects. Additionally, the report also performs SWOT analysis, Porter’s Five Forces analysis, speculation attainability investigation, and venture return investigation.
To learn more details about the Global Cell-Free DNA (cfDNA) Testing Market report, visit @ https://www.emergenresearch.com/industry-report/cell-free-dna-market
Emergen Research has segmented the global Cell-Free DNA (cfDNA) Testing Market on the basis of type, technology, application, and region:
- Type Outlook (Revenue, USD Billion; 2017-2027)
- Cell-free fetal DNA (NIPT)
- Circulating tumor DNA
- Donor-derived cell-free DNA
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- Application Outlook (Revenue, USD Billion; 2017-2027)
Global Cell-Free DNA (cfDNA) Testing Market Geographical Landscape – Synopsis:
- The report closely studies the growth trajectory of the global Cell-Free DNA (cfDNA) Testing market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.
- The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
- Moreover, the report encases an exhaustive geographical study of the market, emphasizing the business growth prospects and market barriers for each of the key market regions.
Proceed To Buy: https://www.emergenresearch.com/select-license/156
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cell-Free DNA (cfDNA) testing Market Segmentation & Impact Analysis
4.1. Cell-Free DNA (cfDNA) testing Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
184.108.40.206. Increasing incidents of chronic disease
220.127.116.11. Growing demand for non-invasive testing methodologies
4.2.3. Market restraints analysis
18.104.22.168. Lack of standardization
22.214.171.124. Unfavorable legal and regulatory rules
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Cell-Free DNA (cfDNA) testing Market By Type Insights & Trends, Revenue (USD Billion)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.1. Cell-free fetal DNA (NIPT)
5.1.2. Circulating tumor DNA
5.1.3. Donor-derived cell-free DNA
Key Objectives of the Report:
- Analysis and estimation of the Cell-Free DNA (cfDNA) Testing market size and share for the projected period of 2020-2027
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Cell-Free DNA (cfDNA) Testing market
Global Cell-Free DNA (cfDNA) Testing Market Highlights:
- Regional demand estimation and forecast
- Product Mix Matrix
- R&D Analysis
- Cost-Benefit Analysis
- Pre-commodity pricing volatility
- Supply chain optimization analysis
- Technological updates analysis
To get a discount on the Global Cell-Free DNA (cfDNA) Testing Market report, visit @ https://www.emergenresearch.com/request-discount/156
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Read similar reports by Emergen Research:
RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market
Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
Regenerative Medicine Market: https://www.emergenresearch.com/industry-report/regenerative-medicine-market
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Molecular Diagnostics Point of Care Market: https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: firstname.lastname@example.org Facebook | LinkedIn | Twitter | Blogs